1. Home
  2. SRDX vs OLP Comparison

SRDX vs OLP Comparison

Compare SRDX & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • OLP
  • Stock Information
  • Founded
  • SRDX 1979
  • OLP 1982
  • Country
  • SRDX United States
  • OLP United States
  • Employees
  • SRDX N/A
  • OLP N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • OLP Real Estate Investment Trusts
  • Sector
  • SRDX Health Care
  • OLP Real Estate
  • Exchange
  • SRDX Nasdaq
  • OLP Nasdaq
  • Market Cap
  • SRDX 402.2M
  • OLP 478.2M
  • IPO Year
  • SRDX 1998
  • OLP N/A
  • Fundamental
  • Price
  • SRDX $41.40
  • OLP $20.61
  • Analyst Decision
  • SRDX Buy
  • OLP
  • Analyst Count
  • SRDX 3
  • OLP 0
  • Target Price
  • SRDX $43.00
  • OLP N/A
  • AVG Volume (30 Days)
  • SRDX 252.6K
  • OLP 77.8K
  • Earning Date
  • SRDX 11-05-2025
  • OLP 11-06-2025
  • Dividend Yield
  • SRDX N/A
  • OLP 8.70%
  • EPS Growth
  • SRDX N/A
  • OLP N/A
  • EPS
  • SRDX N/A
  • OLP 1.54
  • Revenue
  • SRDX $120,801,000.00
  • OLP $97,423,000.00
  • Revenue This Year
  • SRDX N/A
  • OLP $8.44
  • Revenue Next Year
  • SRDX $3.38
  • OLP $3.05
  • P/E Ratio
  • SRDX N/A
  • OLP $13.45
  • Revenue Growth
  • SRDX N/A
  • OLP 9.29
  • 52 Week Low
  • SRDX $25.87
  • OLP $19.62
  • 52 Week High
  • SRDX $41.67
  • OLP $30.45
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 83.94
  • OLP 46.46
  • Support Level
  • SRDX $26.00
  • OLP $19.98
  • Resistance Level
  • SRDX $28.67
  • OLP $20.79
  • Average True Range (ATR)
  • SRDX 0.94
  • OLP 0.40
  • MACD
  • SRDX 1.54
  • OLP 0.11
  • Stochastic Oscillator
  • SRDX 98.23
  • OLP 70.49

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About OLP One Liberty Properties Inc.

One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.

Share on Social Networks: